These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9056157)

  • 41. Nephrotoxicity of contrast media in high-risk patients with renal insufficiency: comparison of low- and high-osmolar contrast agents.
    Deray G; Bellin MF; Boulechfar H; Baumelou B; Koskas F; Baumelou A; Grellet J; Jacobs C
    Am J Nephrol; 1991; 11(4):309-12. PubMed ID: 1799190
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of iopromide with iopamidol and iohexol for contrast-enhanced computed tomography.
    Goldberg SN; Abrahams J; Drayer BP; Golding S; Bernardino M; Brunetti J
    Invest Radiol; 1994 May; 29 Suppl 1():S76-83; discussion S93. PubMed ID: 8071050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nephrotoxicity of iodixanol versus iopamidol inpatients with chronic kidney disease and diabetes mellitus undergoing coronary angiographic procedures.
    Solomon R
    Am Heart J; 2010 Feb; 159(2):e7; author reply e9. PubMed ID: 20152210
    [No Abstract]   [Full Text] [Related]  

  • 44. The osmolality of nonionic, iodinated contrast agents as an important factor for renal safety.
    Lenhard DC; Pietsch H; Sieber MA; Ernst R; Lengsfeld P; Ellinghaus P; Jost G
    Invest Radiol; 2012 Sep; 47(9):503-10. PubMed ID: 22864374
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of non-ionic iodinated contrast media on patient heart rate and pressures during intra-cardiac or intra-arterial injection.
    Schmid I; Didier D; Pfammatter T; Garachemani A; Fleisch M; Kirchin MA; Meier B
    Int J Cardiol; 2007 Jun; 118(3):389-96. PubMed ID: 17376548
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of sodium on the fibrillatory propensity of nonionic contrast media.
    Piao ZE; Murdock DK; Hwang MH; Raymond RM; Scanlon PJ
    Invest Radiol; 1987 Nov; 22(11):895-900. PubMed ID: 3429186
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Enzymuria following administration of contrast media in hypertensive rats].
    Wrigge P; Mályusz M
    Rontgenblatter; 1988 Aug; 41(8):332-5. PubMed ID: 2905826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Occupational allergic contact dermatitis to a non-ionic iodinated contrast medium containing iomeprol.
    Foti C; Bonamonte D; Conserva A; Antelmi AR; Antonaci CE; Angelini G
    Contact Dermatitis; 2008 Oct; 59(4):252-3. PubMed ID: 18844706
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparing the renal safety of isoosmolar versus low-osmolar contrast medium by renal biomarkers N-acetyl-β-D-glucosaminidase and endothelin.
    Semerci T; Cuhadar S; Akçay FA; Aydin TK; Atay A; Köseoglu M; Bayata S
    Angiology; 2014 Feb; 65(2):108-12. PubMed ID: 23359781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of iodixanol and iohexol in renal impairment.
    Chalmers N; Jackson RW
    Br J Radiol; 1999 Jul; 72(859):701-3. PubMed ID: 10624328
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Renal safety of iodixanol.
    McCullough PA
    Expert Rev Cardiovasc Ther; 2006 Sep; 4(5):655-61. PubMed ID: 17081087
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Incidence of ventricular fibrillation during left coronary arteriography in pigs: comparison of a solution of the nonionic dimer iodixanol with solutions of five different nonionic monomers.
    Chai CM; Karlsson JO; Almén T
    Acta Radiol; 2008 Mar; 49(2):150-6. PubMed ID: 18300138
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of iodinated contrast media-induced renal vasoconstriction in human, rabbit, dog, and pig arteries.
    Rauch D; Drescher P; Pereira FJ; Knes JM; Will JA; Madsen PO
    Invest Radiol; 1997 Jun; 32(6):315-9. PubMed ID: 9179705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Constriction of the vasa recta, the vessels supplying the area at risk for acute kidney injury, by four different iodinated contrast media, evaluating ionic, nonionic, monomeric and dimeric agents.
    Sendeski M; Patzak A; Persson PB
    Invest Radiol; 2010 Aug; 45(8):453-7. PubMed ID: 20458252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of nonionic contrast media.
    Almén T
    Invest Radiol; 1985; 20(1 Suppl):S2-9. PubMed ID: 2579043
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [ Use of N-acetylcysteine for the prevention of contrast-induced nephropathy in rats].
    Inci MF; Salk I; Solak O; Vurdem UE; Inci R
    Actas Urol Esp; 2012 Apr; 36(4):210-5. PubMed ID: 22548227
    [No Abstract]   [Full Text] [Related]  

  • 57. Cost-effectiveness of iso- versus low-osmolality contrast media in outpatients with high risk of contrast medium-induced nephropathy.
    Chicaíza-Becerra LA; García-Molina M; Gamboa Ó
    Biomedica; 2012 Jun; 32(2):182-8. PubMed ID: 23242291
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hemodynamic effects of contrast media during coronary angiography: a comparison of three nonionic agents to Hypaque-76.
    Piao ZE; Murdock DK; Hwang MH; Raymond RM; Scanlon PJ
    Cathet Cardiovasc Diagn; 1988; 14(1):53-8. PubMed ID: 3349517
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Early glomerular effects of contrast media in rats: evaluation with a simple method.
    Donadio C; Tramonti G; Lucchesi A; Auner I; Bianchi C
    Ren Fail; 1998 Sep; 20(5):703-6. PubMed ID: 9768438
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical pharmacology of iomeprol.
    Rosati G
    Eur J Radiol; 1994 May; 18 Suppl 1():S51-60. PubMed ID: 8020519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.